Abstract

The structures of the Fc base of various IgG antibodies have been examined with a view to understanding how this region can be used to conjugate IgG to nanoparticles. The base structure is found to be largely consistent across a range of species and subtypes, comprising a hydrophobic region surrounded by hydrophilic residues, some of which are charged at physiological conditions. In addition, atomistic Molecular Dynamics simulations were performed to explore how model nanoparticles interact with the base using neutral and negatively charged gold nanoparticles. Both types of nanoparticle interacted readily with the base, leading to an adaptation of the antibody base surface to enhance the interactions. Furthermore, these interactions left the rest of the domain at the base of the Fc region structurally intact. This implies that coupling nanoparticles to the base of an IgG molecule is both feasible and desirable, since it leaves the antibody free to interact with its surroundings so that antigen-binding functionality can be retained. These results will therefore help guide future attempts to develop new nanotechnologies that exploit the unique properties of both antibodies and nanoparticles.

Details

Title
Exploiting the Fc base of IgG antibodies to create functional nanoparticle conjugates
Author
Al Qaraghuli, Mohammed M. 1 ; Kubiak-Ossowska, Karina 2 ; Ferro, Valerie A. 3 ; Mulheran, Paul A. 4 

 University of Strathclyde, EPSRC Future Manufacturing Research Hub for Continuous Manufacturing and Advanced Crystallisation, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138); SiMologics Ltd. The Enterprise Hub, Glasgow, UK (GRID:grid.11984.35); University of Strathclyde, Department of Chemical and Process Engineering, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138) 
 University of Strathclyde, Department of Chemical and Process Engineering, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138); University of Strathclyde, Archie-West, Department of Physics, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138) 
 University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138) 
 University of Strathclyde, Department of Chemical and Process Engineering, Glasgow, UK (GRID:grid.11984.35) (ISNI:0000 0001 2113 8138) 
Pages
14832
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3072928740
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.